Hepatitis C virus.

 It is most often mild and anicteric but occasionally severe with fulminant hepatic failure. It is caused an RNA virus, which may be transmitted parenterally (a cause of post-transfusion hepatitis); the route of transmission undetermined in 40%-50% of cases
a. 90% of blood transfusion-related hepatitis is caused by hepatitis C.
b. 50% progress to chronic disease.
c. Increased risk for hepatocellular carcinoma.

d. Incubation period: ranges from 2 to 26 weeks, but averages 8 weeks.
-  Antibody is detected by enzyme-linked immunosorbent,assay (ELISA). The incubation period is between 2 and weeks with peak onset of illness 6-8 weeks after infection 
- Most patients progress to chronic liver disease, specifically chronic persistent hepatitis or chronic active hepatitis 
- Cirrhosis is common in patients with chronic active hepatitis and occurs in 20%-25% of infected patients. HCV is also associated with hepatocellular carcinoma.

e. Treatment and prevention: α-interferon is used to treat chronic hepatitis C. There is currently no vaccine available.

Smallpox (variola)
 - vesicles are well synchronized (same stage of development) and cover the skin and mucous membranes.
 - vesicles rupture and leave pock marks with permanent scarring.

SHOCK

Definition. It is a clinical state of acute inadequacy of perfusion to tissues due to fall in effective circulating blood volume.

This inadequacy can be caused by :

• Increased vascular capacity
• Decreased blood volume
• Altered distribution of available blood
• Defective pumping system

Causes:

(1) Hypovolemic

• Massive hamorrhage (external or  internal).
• Loss of plasma as in bums.
• Dehydration due to severe vomiting, diarrhea  diabetic coma.
• Generalized capillary permeability as in anaphylaxis.

 (2) Cardiogenic

• Myocardial infarction.
• Pulmonary embolism.
• Cardiac tamponade

(3) Peripheral pooling:

• Endotoxic shock.
• Disseminated intravascular coagulation (DIC).

(4) Neurogenic:

• Syncope.
• Contributory factor in trauma, bums etc.

Metabolic changes in shock

• Hyperglycaemia due to glycogenolysis.
• Increased blood lactate and pyruvate due to anaerobic glycolysis. This results in metabolic acidosis.
• Protein catabolism and increased  blood urea.
• Interference with enzyme systems.

 Organs involved in shock

(1) Kidneys:

• Renal tubular necrosis.
• Cortical necrosis.

(2) Lungs:

• Oedema, congestion and haemorrhage.
• Microthrombi.

(3) G.I.T. :

• Mucosal oedema.
• Ulceration and haemorrhage

(4) Degeneration and focal necrosis in:

• Heart.
• Liver.
• Adrenals

(5) Anoxic encephalopathy

Systemic Candidiasis (Candidosis; Moniliasis)

Invasive infections caused by Candida sp, most often C. albicans, manifested by fungemia, endocarditis, meningitis, and/or focal lesions in liver, spleen, kidneys, bone, skin, and subcutaneous or other tissues.

Infections due to Candida sp account for about 80% of all major systemic fungal infections.

Symptoms and Signs

Esophagitis is most often manifested by dysphagia. Symptoms of respiratory tract infections are nonspecific, such as cough. Vaginal infections cause itching, burning, and discharge. Candidemia usually causes fever, but other symptoms are typically nonspecific. Sometimes, a syndrome develops resembling bacterial sepsis, with a fulminating course that may include shock, oliguria, renal shutdown, and disseminated intravascular coagulation.

Hematogenous endophthalmitis starts as white retinal plaques that can cause blindness as destructive inflammation progresses, extending to opacify the vitreous and causing potentially irreversible scarring. Most often, there are no symptoms in early stages of Candida endophthalmitis. If treatment is not begun before symptoms appear, significant or even total loss of vision is likely to occur in the affected eye. In neutropenic patients, eye involvement is more often manifested by retinal hemorrhages; papulonodular, erythematous, and vasculitic skin lesions may also develop.